| Oct 24 |
Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
|
| Oct 24 |
How Sanofi Was Caught in The Middle of a €16 Billion Public Brawl
|
| Oct 22 |
The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi
|
| Oct 21 |
Sanofi Deal Jitters Imperil Stock’s Big Rebound
|
| Oct 21 |
Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale
|
| Oct 21 |
Sanofi’s $17bn sale of Opella to US investors advances following government deal
|
| Oct 21 |
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
|
| Oct 21 |
Sanofi moves ahead with CD&R deal for stake in consumer business
|
| Oct 21 |
Sanofi Enters Binding Talks to Sell Controlling Opella Stake to CD&R
|
| Oct 21 |
Trending tickers: Boeing, Sanofi, SAP, Nokia and Tata Consumer Products
|
